South Dakota Cannabis Legislation

SB39 revises industrial hemp provisions, impacting South Dakota's hemp industry, farmers, and consumers of hemp-derived products.

SB42 increases penalties for possessing, delivering, or ingesting controlled substances, including cannabis, within South Dakota correctional facilities, impacting inmates and their visitors.

HB1099 reschedules FDA-approved crystalline psilocybin to Schedule IV in South Dakota, easing access for patients and potentially impacting future medical research and product availability.

HB1016 modifies South Dakota's controlled substances schedule, impacting patients and consumers by potentially altering access to or penalties for certain substances.

HB1160 repeals South Dakota's medical marijuana oversight committee, impacting administrative oversight for patients and the public.

HB1065 revises the medical cannabis affirmative defense, impacting patient protections in South Dakota by clarifying legal use in prosecutions.

HB1255 required the South Dakota Department of Health to accept veteran medical records for cannabis card applications, easing access for veterans.

HB1211 creates a digital registry ID card for South Dakota medical cannabis patients, streamlining access and verification.

SB194 limited medical cannabis potency, impacting patient access to higher-THC products and potentially the market for operators in South Dakota.

SB181 repeals South Dakota's medical cannabis program if cannabis is federally rescheduled, impacting patient access and the existing regulated market.

SB143 required the South Dakota Department of Health to annually report on public health effects of cannabis use, providing data for future policy decisions.

SB95 required medical cannabis cardholders to provide their card or number to law enforcement upon request, impacting patient privacy and law enforcement interaction in South Dakota.

HB1053 required terminal care facilities to allow terminally ill patients to use medical cannabis, impacting patient rights and facility policies in South Dakota.

SB61 banned hemp-derived intoxicants for non-medical use, impacting consumers and the nascent cannabis industry in South Dakota.